About
Dr. McCarthy serves as the Executive Chairman of Primera Diagnostics. He currently is a Venture Partner with Ampersand Ventures and is also a member of the Boards of Directors of Viracor-IBT Laboratories, Magellan Biosciences, Dynex, and Bako Pathology. Previously, he served as Chairman, CEO and CTO of Focus Diagnostics; as President of Boehringer Mannheim Diagnostics; and as VP of R&D and VP and General Manager at Becton Dickinson & Company. Dr. McCarthy has also served on the faculties of the Cornell University School of Medicine, the University of North Carolina School of Medicine, and the Johns Hopkins School of Medicine. He has directed clinical laboratories at the Memorial Sloan-Kettering Cancer Center and at the North Carolina Memorial Hospital.
Position in the VCSift Database
- • 20 investors at Ampersand Capital Partners are tracked.
- • 421 investors hold the Venture Partner role in VCSift. Laurence McCarthy is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
Contact Information
Find more investors like Laurence
Search Investors